LifeArc Revenue and Competitors

UK

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • LifeArc's estimated annual revenue is currently $54.3M per year.(i)
  • LifeArc's estimated revenue per employee is $127,500

Employee Data

  • LifeArc has 426 Employees.(i)
  • LifeArc grew their employee count by 27% last year.

LifeArc's People

NameTitleEmail/Phone
1
Interim Chief People OfficerReveal Email/Phone
2
Executive Assistant to Chief Communications OfficerReveal Email/Phone
3
Chief Scientific Officer at LifeArcReveal Email/Phone
4
Academic Engagement OfficerReveal Email/Phone
5
Head IT DeliveryReveal Email/Phone
6
Head EventsReveal Email/Phone
7
Head BrandReveal Email/Phone
8
Head Digital MarketingReveal Email/Phone
9
Head ContentReveal Email/Phone
10
Head Therapeutic PlatformsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.4M2441%N/AN/A
#2
$2961.7M192046%N/AN/A
#3
$8.4M82-15%N/AN/A
#4
$7.9M771%N/AN/A
#5
$6.5M6622%N/AN/A
#6
$233.9M1638N/AN/AN/A
#7
$8.7M85N/AN/AN/A
#8
$133.1M9326%N/AN/A
#9
$9.7M95-9%N/AN/A
#10
$6.3M6930%N/AN/A
Add Company

What Is LifeArc?

LifeArc® is a medical research charity that pioneers new ways to turn great science into greater patient impact. We have a 25 year legacy of helping scientists and organisations advance their research into therapeutics and diagnostics for patients, including Keytruda®(cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) and Entyvio® (Crohn’s disease) and a test for antimicrobial resistance. Find out more about how we fund, protect and develop much needed research at Lifearc.org or Twitter @lifearc1

keywords:N/A

N/A

Total Funding

426

Number of Employees

$54.3M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LifeArc News

2022-04-20 - CNN's 'Mission: Ahead' meets the pioneers pushing the ...

Hundreds of organizations have adopted the company's tools, Nanome says, including LifeArc, a UK-based medical research charity.

2022-04-20 - AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia

... EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$132.5M42648%$109.4M
#2
$77.2M426N/AN/A
#3
$77.2M426N/AN/A
#4
$79.9M42618%N/A
#5
$109.2M426-6%N/A